Urothelial Cancer

Follow along on our year-long guide to Urothelial Cancer (UC), an exploration of the latest recommendations and research on diagnosis, treatment, and management of this most common type of bladder cancer. UCs originate in the urothelial cells that line the bladder, as well as the urethra, ureters, renal pelvis, and certain other organs. The cells are also called transitional because they can vary in shape and stretch, and UC is thus also sometimes referred to as transitional cell cancer. Each monthly installment of the Medical Journey will delve into another aspect of urothelial cancer, including possible signs and symptoms, genetic factors, related conditions, treatment options, coping strategies, and lessons learned from unique case studies -- all of which have undergone expert review. Every installment will also include a separate, downloadable, printable information resource for patients.

–Hematuria often the presenting sign

Patient Handout

–MRI emerging as adjunctive tool

Patient Handout

–Treatment landscape for BCG-unresponsive bladder/urothelial cancer is expanding

Patient Handout

–Single-docking, robotic-assisted nephroureterectomy proved key; believed to be first report of the approach

Coming Soon

Atopic Dermatitis Cardiomyopathy Endometriosis Heart Failure Melanoma Osteoporosis Rheumatoid Arthritis Ulcerative Colitis Urothelial Cancer